PL2285357T3 - Kompozycja farmaceutyczna zawierająca brivaracetam - Google Patents
Kompozycja farmaceutyczna zawierająca brivaracetamInfo
- Publication number
- PL2285357T3 PL2285357T3 PL09753941T PL09753941T PL2285357T3 PL 2285357 T3 PL2285357 T3 PL 2285357T3 PL 09753941 T PL09753941 T PL 09753941T PL 09753941 T PL09753941 T PL 09753941T PL 2285357 T3 PL2285357 T3 PL 2285357T3
- Authority
- PL
- Poland
- Prior art keywords
- brivaracetam
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
- MSYKRHVOOPPJKU-BDAKNGLRSA-N brivaracetam Chemical compound CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1 MSYKRHVOOPPJKU-BDAKNGLRSA-N 0.000 title 1
- 229960002161 brivaracetam Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pulmonology (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08009919 | 2008-05-30 | ||
| EP09753941.5A EP2285357B8 (en) | 2008-05-30 | 2009-05-28 | Pharmaceutical compositions comprising brivaracetam |
| PCT/EP2009/056570 WO2009144286A1 (en) | 2008-05-30 | 2009-05-28 | Pharmaceutical compositions comprising brivaracetam |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2285357T3 true PL2285357T3 (pl) | 2014-08-29 |
Family
ID=39714168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09753941T PL2285357T3 (pl) | 2008-05-30 | 2009-05-28 | Kompozycja farmaceutyczna zawierająca brivaracetam |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8435564B2 (pl) |
| EP (1) | EP2285357B8 (pl) |
| JP (1) | JP5553452B2 (pl) |
| CN (1) | CN102046153B (pl) |
| BR (1) | BRPI0912161A2 (pl) |
| CA (1) | CA2722093C (pl) |
| DK (1) | DK2285357T3 (pl) |
| ES (1) | ES2465478T3 (pl) |
| PL (1) | PL2285357T3 (pl) |
| WO (1) | WO2009144286A1 (pl) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2563339A1 (en) | 2010-04-29 | 2013-03-06 | Lupin Limited | Controlled release pharmaceutical compositions of brivaracetam |
| MX390695B (es) * | 2010-09-21 | 2025-03-21 | Intekrin Therapeutics Inc | Composiciones farmaceuticas solidas antidiabeticas |
| EP3397253A1 (en) | 2015-12-30 | 2018-11-07 | Adamas Pharmaceuticals, Inc. | Methods and compositions for the treatment of seizure-related disorders |
| EP3634378A1 (en) * | 2017-06-09 | 2020-04-15 | Zoetis Broomhill IP Limited | Intramammary veterinary composition |
| EP3675842A4 (en) | 2017-08-31 | 2021-05-19 | Purdue Pharma L.P. | PHARMACEUTICAL DOSAGE FORMS |
| CN109833300A (zh) * | 2017-11-28 | 2019-06-04 | 浙江京新药业股份有限公司 | 一种抗癫痫药物口服组合物及其制备方法 |
| CN110638743B (zh) * | 2019-10-25 | 2023-03-28 | 乐普制药科技有限公司 | 一种含布立西坦的组合物 |
| CN111407738A (zh) * | 2020-04-03 | 2020-07-14 | 江苏艾立康药业股份有限公司 | 一种布立西坦控释制剂及其制备方法 |
| EP3964201A4 (en) * | 2020-07-09 | 2022-12-28 | Shanghai Bocimed Pharmaceutical Co., Ltd. | Brivaracetam pharmaceutical composition, preparation method therefor and application thereof |
| US20240148693A1 (en) * | 2021-03-17 | 2024-05-09 | Changsha Jingyi Pharmaceutical Technology Co., Ltd | Composition, preparation method therefor, and use thereof |
| CN115192572B (zh) * | 2021-04-08 | 2023-09-19 | 成都同道慧宜生物医药科技有限公司 | 布立西坦药剂、其制备方法和应用 |
| CN115721624A (zh) * | 2021-08-25 | 2023-03-03 | 北京海美源医药科技有限公司 | 一种布立西坦药物组合物及其制备方法和其应用 |
| US12133918B2 (en) | 2021-10-01 | 2024-11-05 | Griffin Gamma, Llc | Partially pre-gelatinized cassava starch as pharmaceutical excipient |
| WO2023125348A1 (zh) * | 2021-12-27 | 2023-07-06 | 广东东阳光药业有限公司 | 布立西坦片剂及其制备方法 |
| CN118416004A (zh) | 2023-02-02 | 2024-08-02 | 泰州越洋医药开发有限公司 | 一种布立西坦双释三层片及其制备方法 |
| EP4491176A1 (en) * | 2023-07-14 | 2025-01-15 | Sanovel Ilac Sanayi ve Ticaret A.S. | A film coated tablet comprising brivaracetam |
| EP4491177A1 (en) * | 2023-07-14 | 2025-01-15 | Sanovel Ilac Sanayi ve Ticaret A.S. | Film coated tablets of brivaracetam |
| TR2023015500A1 (tr) * | 2023-11-22 | 2025-06-23 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Bri̇varasetam i̇çeren deği̇şti̇ri̇lmi̇ş salimli bi̇r tablet kompozi̇syonu |
| EP4559456A1 (en) | 2023-11-22 | 2025-05-28 | Sanovel Ilac Sanayi ve Ticaret A.S. | A modified release tablet of brivaracetam |
| EP4559457A1 (en) | 2023-11-22 | 2025-05-28 | Sanovel Ilac Sanayi ve Ticaret A.S. | A modified release tablet composition of brivaracetam |
| TR2023015501A1 (tr) * | 2023-11-22 | 2025-06-23 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Bri̇varasetam i̇çeren deği̇şti̇ri̇lmi̇ş salimli bi̇r tablet |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9518953D0 (en) * | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
| RU2346996C2 (ru) | 2004-06-29 | 2009-02-20 | ЮРОПИЭН НИКЕЛЬ ПиЭлСи | Усовершенствованное выщелачивание основных металлов |
| ES2294979T1 (es) * | 2005-01-27 | 2008-04-16 | Alembic Limited | Formulacion de levetiracetam de liberacion prolongada. |
| WO2006090275A1 (en) * | 2005-02-24 | 2006-08-31 | Pfizer Limited | Treatment of incontinence |
| EP1895898B1 (en) | 2005-06-29 | 2011-02-16 | Compumedics Limited | Sensor assembly with conductive bridge |
| TW200735878A (en) * | 2005-11-18 | 2007-10-01 | Astrazeneca Ab | Pharmaceutical compositions |
| PL1954241T3 (pl) * | 2005-11-28 | 2013-03-29 | Orexigen Therapeutics Inc | Formulacja zonisamidu o przedłużonym uwalnianiu |
| US8338621B2 (en) * | 2005-12-21 | 2012-12-25 | Ucb S.A. | Process for the preparation of 2-oxo-1-pyrrolidine derivatives |
| AU2006335344A1 (en) * | 2006-01-11 | 2007-07-19 | Teva Pharmaceutical Industries Ltd. | Controlled release formulation of divalproic acid and its derivatives |
| CN101506157B (zh) * | 2006-06-08 | 2013-07-24 | Ucb医药有限公司 | 吡咯烷酮共结晶 |
| JP2006335771A (ja) * | 2006-09-22 | 2006-12-14 | Takeda Chem Ind Ltd | 徐放性製剤およびその製造方法 |
| JP2010506855A (ja) * | 2006-10-12 | 2010-03-04 | アボット ラボラトリーズ | 医薬組成物 |
-
2009
- 2009-05-28 CA CA2722093A patent/CA2722093C/en active Active
- 2009-05-28 ES ES09753941.5T patent/ES2465478T3/es active Active
- 2009-05-28 JP JP2011511013A patent/JP5553452B2/ja active Active
- 2009-05-28 US US12/993,704 patent/US8435564B2/en active Active
- 2009-05-28 BR BRPI0912161A patent/BRPI0912161A2/pt not_active IP Right Cessation
- 2009-05-28 WO PCT/EP2009/056570 patent/WO2009144286A1/en not_active Ceased
- 2009-05-28 DK DK09753941.5T patent/DK2285357T3/da active
- 2009-05-28 PL PL09753941T patent/PL2285357T3/pl unknown
- 2009-05-28 EP EP09753941.5A patent/EP2285357B8/en not_active Revoked
- 2009-05-28 CN CN200980120221.XA patent/CN102046153B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN102046153A (zh) | 2011-05-04 |
| HK1153141A1 (en) | 2012-03-23 |
| EP2285357A1 (en) | 2011-02-23 |
| CA2722093C (en) | 2015-04-28 |
| ES2465478T8 (es) | 2014-08-22 |
| JP2011521927A (ja) | 2011-07-28 |
| US20110091547A1 (en) | 2011-04-21 |
| EP2285357B8 (en) | 2014-07-23 |
| BRPI0912161A2 (pt) | 2015-10-06 |
| CN102046153B (zh) | 2015-06-17 |
| JP5553452B2 (ja) | 2014-07-16 |
| DK2285357T3 (da) | 2014-06-02 |
| ES2465478T3 (es) | 2014-06-05 |
| EP2285357B1 (en) | 2014-05-07 |
| CA2722093A1 (en) | 2009-12-03 |
| US8435564B2 (en) | 2013-05-07 |
| WO2009144286A1 (en) | 2009-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2285357B8 (en) | Pharmaceutical compositions comprising brivaracetam | |
| GB0814695D0 (en) | Pharmaceutical compositions | |
| PT2323623T (pt) | Composições farmacêuticas | |
| IL247741A0 (en) | pharmaceutical preparations | |
| IL228817A0 (en) | Pharmaceutical compounds | |
| EP2222313A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| IL211886A0 (en) | Solid pharmaceutical composition | |
| GB0707127D0 (en) | Pharmaceutical compositions | |
| IL208387A0 (en) | Pharmaceutical composition | |
| EP2146695A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| ZA201100871B (en) | Solid pharmaceutical composition | |
| GB0709811D0 (en) | Pharmaceutical compositions | |
| IL206487A0 (en) | Pharmaceutical compositions | |
| ZA201006224B (en) | Pharmaceutical composition | |
| GB2464200B (en) | Pharmaceutical composition | |
| GB0712454D0 (en) | Pharmaceutical compositions | |
| GB0817969D0 (en) | Pharmaceutical composition | |
| GB0800659D0 (en) | Pharmaceutical Compositions | |
| GB2454923B (en) | Pharmaceutical compositions | |
| EP2236135A4 (en) | STABLE PHARMACEUTICAL COMPOSITION | |
| IL201394A0 (en) | Niacin - based pharmaceutical compositions | |
| GB0802024D0 (en) | Pharmaceutical compositions | |
| GB0806156D0 (en) | Pharmaceutical compositions | |
| GB0806283D0 (en) | Pharmaceutical compositions | |
| EP2308842A4 (en) | PHARMACEUTICAL COMPOSITIONS |